← FDA DRUG APPROVALS

FDA ANDA · ANDA070803

ENFLURANE

Sponsor: ABBOTT

APPLICATION
ANDA070803
TYPE
ANDA
ORIGINAL APPROVAL
1987-07-27
LATEST ACTION
1999-07-08
ROUTE
INHALATION
DOSAGE FORM
LIQUID
MARKETING STATUS
Discontinued

Products

ENFLURANEDiscontinued
ENFLURANE 99.9% · LIQUID · INHALATION

Approval history

1999-07-08Manufacturing (CMC) · Supplement 3AP
1997-01-16Labeling · Supplement 2AP
1987-07-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →